217
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX‐2 selective Inhibitor etoricoxib

, , , &
Pages 2365-2374 | Accepted 28 Aug 2006, Published online: 24 Oct 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Gerhard Zingler, Birgit Hermann, Tim Fischer & Thomas Herdegen. (2016) Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks. Expert Review of Clinical Pharmacology 9:11, pages 1479-1492.
Read now
M. Greenwald, P.M. Peloso, D. Mandel, O. Soto, A. Mehta, N. Frontera, J.A. Boice, X.J. Zhan & S.P. Curtis. (2011) Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. Current Medical Research and Opinion 27:10, pages 2033-2042.
Read now
Anthony Sebba. (2008) Efficacy and safety of etoricoxib in the treatment of osteoarthritis. Expert Review of Clinical Pharmacology 1:3, pages 345-355.
Read now
Alan Matsumoto, Agustin Melian, Arvind Shah & Sean P. Curtis. (2007) Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial. Current Medical Research and Opinion 23:9, pages 2259-2268.
Read now

Articles from other publishers (14)

A. E. Karateev. (2020) Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug. Neurology, Neuropsychiatry, Psychosomatics 12:2, pages 125-130.
Crossref
A. E. Karateev. (2020) The therapeutic potential of etoricoxib in clinical practice. Modern Rheumatology Journal 14:1, pages 108-117.
Crossref
Wanruchada Katchamart, Pongthorn Narongroeknawin, Parawee Chevaisrakul, Pornchai Dechanuwong, Ajanee Mahakkanukrauh, Nuntana Kasitanon, Rattapol Pakchotanon, Kittiwan Sumethkul, Parichat Ueareewongsa, Sittichai Ukritchon, Thitirat Bhurihirun, Kittikorn Duangkum, Porntip Intapiboon, Samanan Intongkam, Wimol Jangsombatsiri, Kanon Jatuworapruk, Naravadee Kositpesat, Pawinee Leungroongroj, Wiyanoot Lomarat, Chonachan Petcharat, Siriluck Sittivutworapant, Patcharawan Suebmee, Pongchirat Tantayakom, Worakan Tipsing, Paijit Asavatanabodee, Praveena Chiowchanwisawakit, Chingching Foocharoen, Ajchara Koolvisoot, Worawit Louthrenoo, Boonjing Siripaitoon, Kitti Totemchokchyakarn & Tasanee Kitumnuaypong. (2017) Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. International Journal of Rheumatic Diseases 20:9, pages 1142-1165.
Crossref
Yen-Fu Chen, Karla Hemming, Peter J. Chilton, Keshav K. Gupta, Douglas G. Altman & Richard J. Lilford. (2014) Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review. Journal of Clinical Epidemiology 67:12, pages 1309-1319.
Crossref
Andrew Whelton & Allan Gibofsky. (2011) Minimizing Cardiovascular Complications During the Treatment of Osteoarthritis. American Journal of Therapeutics 18:6, pages 466-476.
Crossref
Jonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder & Christopher J Edwards. (2011) Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database of Systematic Reviews.
Crossref
F Salvo, A Fourrier-Réglat, F Bazin, P Robinson, N Riera-Guardia, M Haag, A P Caputi, N Moore, M C Sturkenboom & A Pariente. (2011) Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials. Clinical Pharmacology & Therapeutics 89:6, pages 855-866.
Crossref
William J. Elliott. (2010) Do the Blood Pressure Effects of Nonsteroidal Antiinflammatory Drugs Influence Cardiovascular Morbidity and Mortality?. Current Hypertension Reports 12:4, pages 258-266.
Crossref
Katherine F. Croom & M. Asif A. Siddiqui. (2009) Etoricoxib. Drugs 69:11, pages 1513-1532.
Crossref
Panagiotis G. Tsailas, George C. Babis, Konstantinos Nikolopoulos, Panayotis N. Soucacos & Dimitrios S. Korres. (2009) The Effectiveness of Two COX-2 Inhibitors in the Prophylaxis Against Heterotopic New Bone Formation: An Experimental Study in Rabbits. Journal of Surgical Research 151:1, pages 108-114.
Crossref
Todd M. Listwa & Stephen H. Thomas. 2009. Emergency Department Analgesia. Emergency Department Analgesia 94 110 .
Shaojun Shi & Ulrich Klotz. (2007) Clinical use and pharmacological properties of selective COX-2 inhibitors. European Journal of Clinical Pharmacology 64:3, pages 233-252.
Crossref
James M Brophy. (2008) Cardiovascular effects of cyclooxygenase-2 inhibitors. Current Opinion in Internal Medicine 7:1, pages 29-36.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.